Ceruminolytic effects of docusate sodium: A randomized, controlled trial

Citation
Aj. Singer et al., Ceruminolytic effects of docusate sodium: A randomized, controlled trial, ANN EMERG M, 36(3), 2000, pp. 228-232
Citations number
10
Categorie Soggetti
Aneshtesia & Intensive Care
Journal title
ANNALS OF EMERGENCY MEDICINE
ISSN journal
01960644 → ACNP
Volume
36
Issue
3
Year of publication
2000
Pages
228 - 232
Database
ISI
SICI code
0196-0644(200009)36:3<228:CEODSA>2.0.ZU;2-Y
Abstract
Study objective: Assessment of the tympanic membrane is often impeded by th e presence of cerumen. We compared the ceruminolytic effects of triethanola mine polypeptide and docusate sodium in patients with cerumen. Methods: We conducted a prospective, randomized, controlled, double-blind t rial on a convenience sample of cooperative adult and pediatric patients pr esenting to a university-based emergency department who required removal of cerumen to visualize the tympanic membrane. Structured data collection was performed, and the physician determined whether visualization of the tympa nic membrane was partially or totally obscured by cerumen (interobserver ag reement, rho=0.79). Patients received intra-aural instillation of 1 mL of e ither docusate sodium or triethanolamine polypeptide in a liquid form. If n ot completely cleared within 15 minutes, the external ear canal was irrigat ed with 50 or 100 mL of normal saline solution and additional attempts to v isualize the tympanic membrane were made. The main outcome was the proporti on of ears in which the tympanic membrane could be totally visualized after ceruminolytic instillation with or without irrigation. This study had 80% power to detect a 40% difference between groups in the proportion of totall y visualized tympanic membranes (chi(2) test, alpha=.05). Results: Of 50 enrolled patients, 23 received triethanolamine polypeptide a nd 27 received docusate sodium. Mean patient age was 40 years (range 1 to 8 1 years); 35% were female. Groups were similar in age, sex, and proportion of completely obscured tympanic membranes at presentation (78%). The abilit y to completely visualize the tympanic membrane was significantly greater a fter treatment with docusate sodium versus triethanolamine polypeptide (81% versus 35%; difference in proportions 47%; 95% confidence interval [CI], 2 2 to 71)particularly in children aged 5 or less (90% versus 0%; difference in proportions 89%; 95% CI 50 to 100). Conclusion: Docusate sodium solution is a more effective ceruminolytic than triethanolamine polypeptide, allowing complete or partial visualization of the tympanic membrane in most patients after a single application when fol lowed with irrigation. Use of docusate sodium as a ceruminolytic should be encouraged, particularly in children.